Cargando…

Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples

BACKGROUND: While human papillomavirus (HPV) DNA testing offers high sensitivity for the detection of significant cervical disease, its specificity is suboptimal given the high prevalence of transient HPV infections (CIN1 or less). Biomarkers to identify those suffering from low grade disease from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevenson, Andrew, Kavanagh, Kim, Pan, Jiafeng, Stevenson, Lynne, Griffin, Heather, Doorbar, John, Scott, Evelyn, Deeny, Miriam, Cuschieri, Kate, Graham, Sheila V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224362/ https://www.ncbi.nlm.nih.gov/pubmed/30218891 http://dx.doi.org/10.1016/j.jcv.2018.08.011

Ejemplares similares

Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease
por: Chambers, George, et al.
Publicado: (2014)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Stratification of HPV-Induced Cervical Pathology using the Virally-Encoded Molecular Marker E4 in Combination with p16 or MCM
por: Griffin, Heather, et al.
Publicado: (2015)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
por: Cameron, Ross L., et al.
Publicado: (2016)

Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen
por: Lee, Sin Hang, et al.
Publicado: (2009)

Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology
por: Cassel, Ana Paula Rebelo, et al.
Publicado: (2014)

Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology
por: Bihl, Michel P., et al.
Publicado: (2017)

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
por: Egawa, Nagayasu, et al.
Publicado: (2015)

Human papillomavirus molecular biology and disease association
por: Doorbar, John, et al.
Publicado: (2015)

Cytological physiognomies and genotype distribution of human papillomaviruses among HPV/HIV co-infected and HPV mono-infected women
por: Karani, Lucy Wanja, et al.
Publicado: (2021)

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
por: Palmer, T J, et al.
Publicado: (2016)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4
por: Nguyen, Tin, et al.
Publicado: (2012)

The Biology of Papillomavirus Latency
por: Maglennon, Gareth Adam, et al.
Publicado: (2012)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Papillomavirus Life Cycle Organization and Biomarker Selection
por: Doorbar, John
Publicado: (2007)

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
por: Song, Fangbin, et al.
Publicado: (2020)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study
por: Cobo, Fernando, et al.
Publicado: (2009)

Cervical Cytology and Human Papillomavirus Testing in Adolescent Women: Implications in Management of a Positive HPV Test
por: Rosa, Marilin, et al.
Publicado: (2014)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology
por: Buick, Catriona, et al.
Publicado: (2021)

Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development
por: Kaur, Gurjeet, et al.
Publicado: (2019)

The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study
por: Xu, Hui-Fang, et al.
Publicado: (2021)

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
por: Kavanagh, Kimberley, et al.
Publicado: (2013)

Nuclear Matrix Protein 22 in Voided Urine Cytology Efficacy in Risk Stratification for Carcinoma of Bladder
por: Sankhwar, Monica, et al.
Publicado: (2013)

Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
por: Ki, Eun Young, et al.
Publicado: (2019)

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
por: Palmer, Tim, et al.
Publicado: (2019)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
por: Bhatia, Ramya, et al.
Publicado: (2023)

Human papillomavirus genotypes and HPV-16 variants distribution among Tunisian women with normal cytology and squamous intraepithelial lesions
por: Ghedira, R., et al.
Publicado: (2016)

Ancient diversification of eukaryotic MCM DNA replication proteins
por: Liu, Yuan, et al.
Publicado: (2009)

Archaeal MCM Proteins as an Analog for the Eukaryotic Mcm2–7 Helicase to Reveal Essential Features of Structure and Function
por: Miller, Justin M., et al.
Publicado: (2015)

Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil
por: Miyaji, Karina Takesaki, et al.
Publicado: (2022)

Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection
por: Saunders-Wood, Taylor, et al.
Publicado: (2022)

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology
por: Lee, Sung-Jong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_esgft9akjcf00tcu3kuqt7r4v0